Wird geladen...
5PSQ-009 Adequacy of use and effectiveness of glp-1 receptor agonists in real clinical practice
BACKGROUND: NICE guidelines recommend the use of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RA) for adults with type-2 diabetes who have a BMI of 35 kg/m(2) or higher, and continue therapy if a reduction of at least 1% in HbA1c and a weight loss of at least 3% in 6 months is achieved. PURPOSE:...
Gespeichert in:
| Veröffentlicht in: | Eur J Hosp Pharm |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535169/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.363 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|